Concepedia

Robert A. Wolff

RA

301

Publications

40.3K

Citations

102

H-Index

1943

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Duke Medical Center

Robert A. Wolff is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1943–2025

301

Publications

301

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.8K citations

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

Navneet K. Dhillon, Bharat B. Aggarwal, Robert A. Newman et al. · Clinical Cancer Research · 2008 · 1.3K citations

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.2K citations · Full text

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1K citations

, , +18

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans et al. · Journal of the American College of Surgeons · 2008 · 813 citations · Full text

Rows per page

1–5 of 301